Figure 1
Figure 1. Coagulation time and inhibition assay.(a) Coagulation times of RBCs/platelets/MPs in each group were evaluated. * and # indicate statistical significance (P < 0.05) from control and MN, respectively. (b) Coagulation times of RBCs/platelets/MPs of MN patients were detected in the absence or presence of 128 nM lactadherin or 40 μg/ml anti-TF. Data are displayed as mean ± SD for triplicate samples of independent experiments (n = 10). MPs: microparticles.

Coagulation time and inhibition assay.(a) Coagulation times of RBCs/platelets/MPs in each group were evaluated. * and # indicate statistical significance (P < 0.05) from control and MN, respectively. (b) Coagulation times of RBCs/platelets/MPs of MN patients were detected in the absence or presence of 128 nM lactadherin or 40 μg/ml anti-TF. Data are displayed as mean ± SD for triplicate samples of independent experiments (n = 10). MPs: microparticles.

Close Modal

or Create an Account

Close Modal
Close Modal